These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11039911)

  • 1. Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-kappaB inhibition.
    Cheng Q; Lee HH; Li Y; Parks TP; Cheng G
    Oncogene; 2000 Oct; 19(42):4936-40. PubMed ID: 11039911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis.
    Fujioka S; Sclabas GM; Schmidt C; Niu J; Frederick WA; Dong QG; Abbruzzese JL; Evans DB; Baker C; Chiao PJ
    Oncogene; 2003 Mar; 22(9):1365-70. PubMed ID: 12618762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer.
    Catz SD; Johnson JL
    Oncogene; 2001 Nov; 20(50):7342-51. PubMed ID: 11704864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 suppresses apoptosis resulting from disruption of the NF-kappa B survival pathway.
    Herrmann JL; Beham AW; Sarkiss M; Chiao PJ; Rands MT; Bruckheimer EM; Brisbay S; McDonnell TJ
    Exp Cell Res; 1997 Nov; 237(1):101-9. PubMed ID: 9417872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis.
    Soares MP; Muniappan A; Kaczmarek E; Koziak K; Wrighton CJ; Steinhäuslin F; Ferran C; Winkler H; Bach FH; Anrather J
    J Immunol; 1998 Nov; 161(9):4572-82. PubMed ID: 9794384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of Bfl-1/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line.
    Kim JK; Kim KD; Lee E; Lim JS; Cho HJ; Yoon HK; Cho MY; Baek KE; Park YP; Paik SG; Choe YK; Lee HG
    Cancer Lett; 2004 Aug; 212(1):61-70. PubMed ID: 15246562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression.
    Baetu TM; Kwon H; Sharma S; Grandvaux N; Hiscott J
    J Immunol; 2001 Sep; 167(6):3164-73. PubMed ID: 11544302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.
    Kim MK; Jeon YK; Woo JK; Choi Y; Choi DH; Kim YH; Kim CW
    Mol Cancer; 2011 Aug; 10():98. PubMed ID: 21843371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
    Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
    Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
    Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLUG is activated by nuclear factor kappa B and confers human alveolar epithelial A549 cells resistance to tumor necrosis factor-alpha-induced apoptosis.
    Wang Y; Yue B; Yu X; Wang Z; Wang M
    World J Surg Oncol; 2013 Jan; 11():12. PubMed ID: 23339680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
    Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB activation is related to the resistance of lung cancer cells to TNF-alpha-induced apoptosis.
    Kim JY; Lee S; Hwangbo B; Lee CT; Kim YW; Han SK; Shim YS; Yoo CG
    Biochem Biophys Res Commun; 2000 Jun; 273(1):140-6. PubMed ID: 10873576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells.
    Cahir-McFarland ED; Davidson DM; Schauer SL; Duong J; Kieff E
    Proc Natl Acad Sci U S A; 2000 May; 97(11):6055-60. PubMed ID: 10811897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human lung cancer: role of TLR7 and TLR8 in cell survival and chemoresistance].
    Cherfils-Vicini J; Damotte D; Fridman WH; Sautès-Fridman C; Cremer I
    Med Sci (Paris); 2010 Apr; 26(4):435-7. PubMed ID: 20412752
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
    Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma.
    Dong G; Chen Z; Kato T; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3495-504. PubMed ID: 10416616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MnSOD overexpression confers cisplatin resistance in lung adenocarcinoma via the NF-κB/Snail/Bcl-2 pathway.
    Chen PM; Cheng YW; Wu TC; Chen CY; Lee H
    Free Radic Biol Med; 2015 Feb; 79():127-37. PubMed ID: 25499851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor-kappaB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53.
    Shinohara T; Miki T; Nishimura N; Nokihara H; Hamada H; Mukaida N; Sone S
    Cancer Res; 2001 Jan; 61(2):673-8. PubMed ID: 11212267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
    Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
    Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.